use of psilocybin in the treatment of psychiatric disorders - review
Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (28)
- Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. 2023-02-01 · Expand citations
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. 2022-10-01 · Expand citations
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. 2021-04-01 · Expand citations
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
- Psilocybin for depression: Considerations for clinical trial design 2019-09-01 · Expand citations
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. 2018-12-01 · Expand citations
- High dose psilocybin is associated with positive subjective effects in healthy volunteers. 2018-07-01 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
- Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
- Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance 2017-01-02 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
- Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
- Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey. 2015-01-01 · Expand citations
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
- Psilocybin--summary of knowledge and new perspectives. 2014-03-01 · Expand citations
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
- The pharmacology of psilocybin. 2002-10-01 · Expand citations
- Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A. 1982-05-01 · Expand citations
- Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singer 1982-05-01 · Expand citations
- OpenAlex W2113099805
- OpenAlex W2999570410
- OpenAlex W4210332402
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.